GRIFOLS USA LLC
- LOS ANGELES, CA 90032-3514
- grifolsusa.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $1.9M
- Awards on record
- 17
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
GRIFOLS USA LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About GRIFOLS USA LLC
- Headquarters
- LOS ANGELES, CA 90032-3514
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEID48FNWJCJ5H5
- CAGE1N5P5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $1.9M
- Awards on record
- 17
- Top funding agencies
- Department of Veterans Affairs · Federal Prison System / Bureau of Prisons
Awards
36C26026F0015
Completed: Period of performance ended Sep 30, 2026PHARM - PROLASTIN-C
Department of Veterans Affairs
- Obligated
- $120K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26026F0019
Completed: Period of performance ended Sep 30, 2026PHARM - PROLASTIN-C
Department of Veterans Affairs
- Obligated
- $111K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26026F0037
Completed: Period of performance ended Sep 30, 2026PROLASTIN-C LIQUID,HUMAN 1000MG/VIL.
Department of Veterans Affairs
- Obligated
- $364K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26025F0037
Completed: Period of performance ended Feb 8, 2026PROLASTIN-C BULK PHARMACY
Department of Veterans Affairs
- Obligated
- $0
- Period of performance
- Feb 7, 2025 – Feb 8, 2026
36C26025F0153
Completed: Period of performance ended Sep 30, 2025PROLASTIN-C LIQUID,HUMAN 1000MG/VIL
Department of Veterans Affairs
- Obligated
- $97.2K
- Period of performance
- Feb 26, 2025 – Sep 30, 2025
36C26325F0017
Completed: Period of performance ended Sep 30, 2025PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $103.3K
- Period of performance
- Oct 11, 2024 – Sep 30, 2025
36C26025F0041
Completed: Period of performance ended Sep 30, 2025PROLASTIN-C LIQUID,HUMAN 1000MG/VIL
Department of Veterans Affairs
- Obligated
- $313.3K
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C26324N0859
Completed: Period of performance ended Feb 19, 2025PROLASTIN FOR FARGO PHARMACY
Department of Veterans Affairs
- Obligated
- $19.3K
- Period of performance
- Sep 9, 2024 – Feb 19, 2025
36C26024F0074
Completed: Period of performance ended Feb 8, 2025PROLASTIN-C
Department of Veterans Affairs
- Obligated
- $96.6K
- Period of performance
- Feb 8, 2024 – Feb 8, 2025
36C26024F0409
Completed: Period of performance ended Sep 30, 2024PROLASTIN LIQUID
Department of Veterans Affairs
- Obligated
- $157.1K
- Period of performance
- May 20, 2024 – Sep 30, 2024
36C26024F0008
Completed: Period of performance ended Sep 30, 2024PROLASTIN-C 1000MG VIALS
Department of Veterans Affairs
- Obligated
- $66.8K
- Period of performance
- Oct 1, 2023 – Sep 30, 2024
36C26024F0023
Completed: Period of performance ended Sep 30, 2024PROLASTIN-C
Department of Veterans Affairs
- Obligated
- $288.9K
- Period of performance
- Oct 1, 2023 – Sep 30, 2024
36C24524N0738
Completed: Period of performance ended Aug 23, 2024PROLASTIN C LIQUID
Department of Veterans Affairs
- Obligated
- $11.5K
- Period of performance
- Jul 17, 2024 – Aug 23, 2024
36C26023F0167
Completed: Period of performance ended Feb 7, 2024PROLASTIN-C LIQUID, HUMAN 100MG/VIL INJ - PUGET SOUND VAHCS
Department of Veterans Affairs
- Obligated
- $104.6K
- Period of performance
- Feb 8, 2023 – Feb 7, 2024
15B50523P00000030
Completed: Period of performance ended Feb 2, 2024PROLASTIN-C LIQUID
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $19.3K
- Period of performance
- Feb 1, 2023 – Feb 2, 2024
36C26023F0270
Completed: Period of performance ended Nov 30, 2023PROLASTIN
Department of Veterans Affairs
- Obligated
- $59.2K
- Period of performance
- Mar 28, 2023 – Nov 30, 2023
36C26023F0005
Completed: Period of performance ended Sep 30, 2023PROLASTIN-C LIQUID, HUMAN 1000MG/VIAL 13533-0705-01
Department of Veterans Affairs
- Obligated
- $502.9K
- Period of performance
- Oct 1, 2022 – Sep 30, 2023
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C26026F0015 under 36F79722D0090 PHARM - PROLASTIN-C | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $120K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26026F0019 under 36F79722D0090 PHARM - PROLASTIN-C | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $111K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26026F0037 under 36F79722D0090 PROLASTIN-C LIQUID,HUMAN 1000MG/VIL. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $364K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26025F0037 under 36F79722D0090 PROLASTIN-C BULK PHARMACY | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $0 | Feb 7, 2025 – Feb 8, 2026 | Completed: Period of performance ended Feb 8, 2026 |
36C26025F0153 under 36F79722D0090 PROLASTIN-C LIQUID,HUMAN 1000MG/VIL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $97.2K | Feb 26, 2025 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26325F0017 under 36F79722D0090 PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $103.3K | Oct 11, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26025F0041 under 36F79722D0090 PROLASTIN-C LIQUID,HUMAN 1000MG/VIL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $313.3K | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26324N0859 under 36F79722D0090 PROLASTIN FOR FARGO PHARMACY | Department of Veterans Affairs | 325412 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $19.3K | Sep 9, 2024 – Feb 19, 2025 | Completed: Period of performance ended Feb 19, 2025 |
36C26024F0074 under 36F79722D0090 PROLASTIN-C | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $96.6K | Feb 8, 2024 – Feb 8, 2025 | Completed: Period of performance ended Feb 8, 2025 |
36C26024F0409 under 36F79722D0090 PROLASTIN LIQUID | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $157.1K | May 20, 2024 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C26024F0008 under 36F79722D0090 PROLASTIN-C 1000MG VIALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $66.8K | Oct 1, 2023 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C26024F0023 under 36F79722D0090 PROLASTIN-C | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $288.9K | Oct 1, 2023 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C24524N0738 under 36F79722D0090 PROLASTIN C LIQUID | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.5K | Jul 17, 2024 – Aug 23, 2024 | Completed: Period of performance ended Aug 23, 2024 |
36C26023F0167 under 36F79722D0090 PROLASTIN-C LIQUID, HUMAN 100MG/VIL INJ - PUGET SOUND VAHCS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $104.6K | Feb 8, 2023 – Feb 7, 2024 | Completed: Period of performance ended Feb 7, 2024 |
15B50523P00000030 PROLASTIN-C LIQUID | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6505DRUGS AND BIOLOGICALS | $19.3K | Feb 1, 2023 – Feb 2, 2024 | Completed: Period of performance ended Feb 2, 2024 |
36C26023F0270 under 36F79722D0090 PROLASTIN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $59.2K | Mar 28, 2023 – Nov 30, 2023 | Completed: Period of performance ended Nov 30, 2023 |
36C26023F0005 under 36F79722D0090 PROLASTIN-C LIQUID, HUMAN 1000MG/VIAL 13533-0705-01 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $502.9K | Oct 1, 2022 – Sep 30, 2023 | Completed: Period of performance ended Sep 30, 2023 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimary
- 423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with GRIFOLS USA LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
